Status:
COMPLETED
Glycaemic Control and Other Clinical Parameters in Adult Type 2 Diabetes Patients on Basal Insulin Initiating Treatment With IDegLira in Routine Clinical Practice in Colombia
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to investigate the glycaemic control and other clinical parameters in adult patients previously treated with basal insulin (with or without OADs) and switched to IDegLira ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Male or female, age above or equal to 18 years at the time of data collection.
- Patient diagnosed with T2D greater than or equal to 12 months prior to data collection.
- The decision to initiate treatment with commercially available IDegLira has been made by the patient and the treating physician before, which is independent from the decision to participate in this study.
- Treated with basal insulin plus/minus OADs prior to initiating IDegLira.
- Available and documented HbA1c measurement below or equal to 12 weeks prior to IDegLira initiation.
- Exclusion criteria:
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
- Diagnosed with type 1 diabetes mellitus, maturity-onset diabetes of the young, latent autoimmune diabetes in adults, gestational diabetes or any hyperglycaemic state other than T2D.
- Women known to be pregnant or breastfeeding during the conduct of the study.
- Patients with basal-bolus insulin prior to IDegLira initiation.
- Participation in another T2D clinical study that involves any clinical intervention or administration of an investigational drug within 3 months prior to initiating IDegLira.
Exclusion
Key Trial Info
Start Date :
March 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2022
Estimated Enrollment :
175 Patients enrolled
Trial Details
Trial ID
NCT05324462
Start Date
March 22 2022
End Date
July 15 2022
Last Update
November 9 2022
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Medellín, Antioquia, Colombia
2
Novo Nordisk Investigational Site
Barranquilla, Atlántico, Colombia
3
Novo Nordisk Investigational Site
Bogotá, Bogota DC, Colombia
4
Novo Nordisk Investigational Site
Montería, Departamento de Córdoba, Colombia